PRESS RELEASE published on 04/04/2025 at 00:00, 8 months 1 day ago Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025 Onco-Innovations Limited's subsidiary, Inka Health Corp., completes analytical work for AstraZeneca Canada, showcasing advancements in pharmaceutical evidence generation and real-world data use Real-world Data Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Pharmaceutical Evidence Generation
BRIEF published on 03/26/2025 at 23:05, 8 months 9 days ago Study Explores Low Toxicity of Onco-Innovations' PNKP Technology Cancer Treatment Radiation Therapy Onco-Innovations PNKP Technology Low Toxicity
BRIEF published on 03/26/2025 at 23:05, 8 months 9 days ago Une étude explore la faible toxicité de la technologie PNKP d'Onco-Innovations Traitement Du Cancer Radiothérapie Onco-Innovations Technologie PNKP Faible Toxicité
PRESS RELEASE published on 03/26/2025 at 23:00, 8 months 9 days ago Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile Onco-Innovations Limited announces successful nanoparticle formulation of PNKP Compound with low toxicity and effective cancer cell targeting in mice, promising safer treatment options Cancer Treatment Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Low Toxicity
BRIEF published on 03/25/2025 at 22:05, 8 months 10 days ago Onco-Innovations Extends Marketing Partnership with MCS Digital Advertising Onco-Innovations Marketing Extension MCS Partnership CAD 600,000 Budget
BRIEF published on 03/25/2025 at 22:05, 8 months 10 days ago Onco-Innovations étend son partenariat marketing avec MCS Publicité Numérique Onco-Innovations Extension Marketing Partenariat MCS Budget De 600 000 $ CA
PRESS RELEASE published on 03/25/2025 at 22:00, 8 months 10 days ago Onco-Innovations Extends Marketing Program Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until May 31, 2025. Company aims to revolutionize cancer treatment with patented technology Patented Technology Cancer Treatment Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services
BRIEF published on 03/24/2025 at 23:05, 8 months 11 days ago Onco-Innovations Updates Proceeds Utilization Strategy Investor Relations Equity Financing Research And Development Onco-Innovations Proceeds Update
BRIEF published on 03/24/2025 at 23:05, 8 months 11 days ago Onco-Innovations met à jour sa stratégie d'utilisation des bénéfices Recherche Et Développement Relations Avec Les Investisseurs Financement Par Actions Onco-Innovations Mise À Jour Des Recettes
PRESS RELEASE published on 03/24/2025 at 23:00, 8 months 11 days ago Onco-Innovations Provides Update on Use of Proceeds Onco-Innovations Limited provides an update on the use of proceeds from its Prospectus, focusing on investor relations activities and increased research and development spending for cancer treatments Investor Relations Research And Development Cancer Treatment Onco-Innovations Limited Use Of Proceeds
Published on 12/05/2025 at 18:45, 16 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 41 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 1 minute ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 46 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 2 hours 1 minute ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 18:58, 3 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 46 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 1 hour 15 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 1 hour 43 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 43 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 50 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 50 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 3 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE